BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6506985)

  • 1. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
    Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
    Uvarova LG; Titaeva MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders].
    Maksimenko TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):737-40. PubMed ID: 6880505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinicobiochemical parallels in borderline neuropsychic disorders].
    Ushakov GK; Maslova AF; Kostiunina ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level].
    Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS
    Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-dynamic analysis of the borderline states of advanced age].
    Semke VIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1369-74. PubMed ID: 3425081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam-induced dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychopharmacology of borderline personality disorders.
    Montgomery SA
    Acta Psychiatr Belg; 1987; 87(3):260-6. PubMed ID: 3673629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level].
    Bochkarev VK; Neznamov GG
    Eksp Klin Farmakol; 1995; 58(4):18-22. PubMed ID: 7580745
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
    Schatzberg AF; Cole JO
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatment for borderline personality disorder.
    Berger PA
    Bull Menninger Clin; 1987 May; 51(3):277-84. PubMed ID: 3580662
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phenazepam in the treatment of borderline forms of neuropsychiatric disorders].
    Kalandarishvili AS; Bortnik TL; Berdina ES; Lesovskaia TV; Aleksandrovskiĭ IuA
    Sov Med; 1979 Jul; (7):8-14. PubMed ID: 41325
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Leitner P; Serfling R
    Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.